Regeneron Pharmaceuticals · Depreciation & Amortization

Latest reported$528.60Mperiod endingJun 30, 2026

REGN Depreciation & Amortization ($800.00K → $528.60M)

Annual Depreciation & Amortization

High-resolution chart · PNG

REGN depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	543,700,000
Dec 31, 2024	482,900,000
Dec 31, 2023	421,000,000
Dec 31, 2022	341,400,000
Dec 31, 2021	286,200,000
Dec 31, 2020	235,900,000
Dec 31, 2019	210,300,000
Dec 31, 2018	148,200,000
Dec 31, 2017	145,467,000
Dec 31, 2016	104,745,000
Dec 31, 2015	74,909,000
Dec 31, 2014	52,686,000
Dec 31, 2013	41,204,000
Dec 31, 2012	36,940,000
Dec 31, 2011	31,082,000
Dec 31, 2010	19,687,000
Dec 31, 2009	14,247,000
Dec 31, 2008	11,287,000
Dec 31, 2007	11,487,000
Dec 31, 2006	14,592,000
Dec 31, 2005	15,504,000
Dec 31, 2004	15,362,000
Dec 31, 2003	12,937,000
Dec 31, 2002	8,454,000
Dec 31, 2001	6,077,000
Dec 31, 2000	4,421,000
Dec 31, 1999	3,400,000
Dec 31, 1998	3,000,000
Dec 31, 1997	4,400,000
Dec 31, 1996	6,100,000
Dec 31, 1995	5,900,000
Dec 31, 1994	4,200,000
Dec 31, 1993	3,100,000
Dec 31, 1992	2,000,000
Dec 31, 1991	800,000